Leu Asp - CAS号查询

Angiotensin II,5-L-isoLeucine-8-L-alanine- (8CI,9CI);
Alanine,N-[1-[N-[N-[N-[N-(N2-a-Aspartylarginyl)valyl]tyrosyl]isoLeucyl]histidyl]prolyl]- (6CI);
5-IsoLeucine-8-alanineangiotensin;
5-IsoLeucine-8-alanine-angiotensin II;
5-L-IsoLeucine-8-L-alanineangiotensin II;
8-Ala-Ang II;
[8-Alanine]-5-isoLeucine-angiotensin II

C44H67N13O12

详情

供应商

116331-58-9

Angiotensin II,1-de-L-Aspartic acid-2-(N-methylglycine)-5-L-isoLeucine-8-L-isoLeucine- (9CI);
[SAR1,ILE7]-ANGIOTENSIN III ACETATE SALT;
SAR-VAL-TYR-ILE-HIS-PRO-ILE ACETATE SALT;
(SAR1,ILE7)-ANGIOTENSIN III;
[sar1, ile7]-angiotensin iii acetate hydrate;
sar-val-tyr-ile-his-pro-ile;
angiotensin III, Sar(1)-Ile(7)-;
[Sar1, Ile7]-Angiotensin III hydrate acetate salt

Angiotensin II,5-L-isoLeucine-;
Alanine,N-[1-[N-[N-[N-[N-(N2-L-a-Aspartyl-L-arginyl)-L-valyl]-L-tyrosyl]-L-isoLeucyl]-L-histidyl]-L-prolyl]-3-phenyl-,L- (6CI,7CI);
10: PN: WO0212471 SEQID: 17 unclaimed sequence;
113: PN:WO2008104000 TABLE: 4 unclaimed sequence;
11: PN: US20030119021 SEQID: 10unclaimed sequence;
1272: PN: US20050069911 SEQID: 1272 unclaimed sequence;
12:PN: US20090088553 SEQID: 86 unclaimed protein;
12: PN: WO0239997 SEQID: 17unclaimed sequence;
134: PN: WO02098448 SEQID: 144 unclaimed sequence;
134: PN:WO02098906 SEQID: 144 unclaimed sequence;
14: PN: WO2004007538 SEQID: 13claimed sequence;
154: PN: WO2009126292 TABLE: 4 unclaimed sequence;
17: PN:US6610497 SEQID: 17 unclaimed sequence;
17: PN: US6884771 SEQID: 17 unclaimedsequence;
17: PN: US6989363 SEQID: 17 unclaimed sequence;
17: PN: WO2006032674SEQID: 15 claimed sequence;
1: PN: CN101015689 SEQID: 1 claimed sequence;
1:PN: CN1706502 PAGE: 2 claimed sequence;
1: PN: US6022696 SEQID: 2 unclaimedsequence;
1: PN: WO0002905 SEQID: 1 claimed protein;

Angiotensin I,1-L-Asparagine-5-L-valine-;
Leucine,N-[N-[N-[1-[N-[N-[N-[N-(N2-L-Asparaginyl-L-arginyl)-L-valyl]-L-tyrosyl]-L-valyl]-L-histidyl]-L-prolyl]-3-phenyl-L-alanyl]-L-histidyl]-(7CI);
Leucine,N-[N-[N-[1-[N-[N-[N-[N-(N2-Asparaginylarginyl)valyl]tyrosyl]valyl]histidyl]prolyl]-3-phenylalanyl]histidyl]-(6CI);
1-Asparagine-5-valine-angiotensin I;
2: PN: WO0069900 SEQID: 651unclaimed sequence;
5-Valine-angiotensin I Aspartic-b-amide;
541: PN: US20090175821 SEQID: 651 claimedprotein;
Asparaginyl1-valyl5-angiotensin

Antrin (rat) (9CI);
L-Phenylalanine,N-[N2-[N2-[N-[N2-[1-[N-[N-(1-L-alanyl-L-prolyl)-L-seryl]-L-a-Aspartyl]-L-prolyl]-L-arginyl]-L-Leucyl]-L-arginyl]-L-glutaminyl]-

Cyclo(L-alanyl-N-methyl-L-phenylalanyl-L-Leucyl-N-methyl-L-tyrosyl-2-aminobenzoyl);
1,4,7,10,13-Benzopentaazacyclohexadecine,cyclic peptide deriv.;
CycloAspeptide A

Cyclo(L-alanyl-L-phenylalanyl-L-Leucyl-N-methyl-L-tyrosyl-2-aminobenzoyl);
1,4,7,10,13-Benzopentaazacyclohexadecine,cyclic peptide deriv.;
CycloAspeptide C

Cyclo(L-alanyl-N-methyl-L-phenylalanyl-L-Leucyl-L-tyrosyl-2-aminobenzoyl)(9CI);
1,4,7,10,13-Benzopentaazacyclohexadecine,cyclic peptide deriv.;
CycloAspeptide B

Glycinamide,L-a-Aspartyl-L-prolyl-L-alanyl-L-phenylalanyl-L-Asparaginyl-L-seryl-L-tryptophyl-;
LeucokininI;
Leukokinin I

Glycinamide,glycyl-L-alanyl-L-a-Aspartyl-L-phenylalanyl-L-tyrosyl-L-seryl-L-tryptophyl-;
LeukokininV, 2-L-alanine-3-L-Aspartic acid-5-L-tyrosine-;
Leucokinin VIII;
LeukokininVIII

Glycinamide, L-a-Aspartyl-L-glutaminylglycyl-L-phenylalanyl-L-Asparaginyl-L-seryl-L-tryptophyl-(9CI);
LeukokininI, 2-L-glutamine-3-glycine-;
Leucokinin III;
Leukokinin III

Glycinamide, L-a-Aspartyl-L-prolylglycyl-L-phenylalanyl-L-seryl-L-seryl-L-tryptophyl-(9CI);
LeukokininI, 3-glycine-5-L-serine-;
Leucokinin II;
Leukokinin II

Glycinamide, L-a-Aspartyl-L-prolyl-L-alanyl-L-phenylalanyl-L-seryl-L-seryl-L-tryptophyl-(9CI);
LeukokininI, 5-L-serine-;
Leucokinin VII;
Leukokinin VII

Glycinamide, L-a-Aspartyl-L-alanyl-L-seryl-L-phenylalanyl-L-histidyl-L-seryl-L-tryptophyl-(9CI);
LeukokininI, 2-L-alanine-3-L-serine-5-L-histidine-;
Leucokinin IV;
Leukokinin IV

3,5-二氯水杨醛

L-Arginine,L-cysteinyl-L-a-Aspartyl-L-prolylglycyl-L-tyrosyl-L-isoLeucylglycyl-L-seryl-;
L-Arginine,N2-[N-[N-[N-[N-[N-[1-(N-L-cysteinyl-L-a-Aspartyl)-L-prolyl]glycyl]-L-tyrosyl]-L-isoLeucyl]glycyl]-L-seryl]-;
15: PN: WO2008150101 SEQID: 15 claimed protein;
1: PN: EP1074563 SEQID: 3unclaimed sequence;
1: PN: EP2113264 SEQID: 1 claimed protein;
1: PN:US20070258889 SEQID: 1 claimed sequence;
1: PN: WO2009019685 PAGE: 12 claimedprotein;
21: PN: WO0004941 PAGE: 32 claimed sequence;
27: PN: KR20090132815PAGE: 3 claimed sequence;
27: PN: KR20090132911 SEQID: 122 claimed protein;
2:PN: WO2007022424 SEQID: 2 claimed protein;
3: PN: US20050288231 PAGE: 2unclaimed sequence;
5: PN: WO2009019685 PAGE: 12 claimed protein;
7: PN:US6180134 SEQID: 7 unclaimed sequence

L-Lysine,glycyl-L-Leucyl-L-Leucyl-L-a-Aspartyl-L-Leucyl-;
L-Lysine,N2-[N-[N-[N-(N-glycyl-L-Leucyl)-L-Leucyl]-L-a-Aspartyl]-L-Leucyl]-;
98: PN: US20040029140 SEQID: 98unclaimed sequence

L-Asparagine,L-valyl-L-isoLeucyl-L-histidyl-;
L-Asparagine,N2-[N-(N-L-valyl-L-isoLeucyl)-L-histidyl]-;
37: PN: WO2005077065 PAGE: 57claimed protein

Leucosulfakinin II(9CI);
LeucosulfakininI, 1-de-L-glutamic acid-2-(5-oxo-L-proline)-3-L-serine-4-L-Aspartic acid-;
L-Phenylalaninamide,5-oxo-L-prolyl-L-seryl-L-a-Aspartyl-L-a-Aspartyl-O-sulfo-L-tyrosylglycyl-L-histidyl-L-methionyl-L-arginyl-

C53H72N16O20S2

详情

供应商

化工产品